2017 Section 7 Green Book

O NCOLYTIC IMMUNOTHERAPY IN CUTANEOUS HEAD AND NECK MELANOMA

FIGURE 3. Duration of response for all patients with a response per endpoint assessment committee (EAC) was cen- sored (marked by arrow) if at the last tumor assessment there was no evi- dence (per EAC) that the response had ended. Probability of being in response was estimated using the Kaplan–Meier method. Because only 1 patient in the granulocyte-macrophage colony-stim- ulating factor (GM-CSF) group had a response lasting > 3 months, probabil- ity of being in response was not calcu- lated for this group.

FIGURE 4. (A) Time to treatment failure per investigator assessment. (B) Overall survival. CI, confidence interval; GM-CSF, granulocyte-macrophage colony-stimulating factor; IQR, interquartile range; NE, not estimable; OS, overall survival.

HEAD & NECK—DOI 10.1002/hed

172